FDA Orange Book
Is there a generic for Contrave?
Contrave contains naltrexone and bupropion. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Contrave (naltrexone and bupropion). The Orange Book shows its last listed patent expires July 2, 2034.
Run it in Rivvi
Map Contrave and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Contrave products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, extended release, oral | 90MG;8MG | Marketed (Rx) | None | 0 | None |
NDA 200063, held by AZURITY PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Contrave patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9107837 | June 4, 2027 | Method of use | U-1639 | 200063 |
| 8722085 | November 8, 2027 | Method of use | U-1585 | 200063 |
| 9125868 | November 8, 2027 | Method of use | U-1585 | 200063 |
| 10307376 | November 8, 2027 | Method of use | U-1585 | 200063 |
| 12048769 | November 8, 2027 | Method of use | U-1585 | 200063 |
| 8318788 | November 8, 2027 | Method of use | U-1584 | 200063 |
| 8088786 | February 3, 2029 | Drug product | None | 200063 |
| 11324741 | May 29, 2029 | Method of use | U-1583 | 200063 |
| 8916195 | February 2, 2030 | Method of use | U-1639 | 200063 |
| 11033543 | January 10, 2031 | Method of use | U-1583 | 200063 |
| 9248123 | January 13, 2032 | Method of use | U-1808 | 200063 |
| 11139056 | June 5, 2033 | Method of use | U-1583 | 200063 |
| 10403170 | June 5, 2033 | Method of use | U-1583 | 200063 |
| 9633575 | June 25, 2033 | Method of use | U-1583 | 200063 |
| 10231964 | July 2, 2034 | Method of use | U-1583 | 200063 |
| 11998542 | July 2, 2034 | Method of use | U-1583 | 200063 |
| 10835527 | July 2, 2034 | Method of use | U-1583 | 200063 |
| 10828294 | July 2, 2034 | Method of use | U-1583 | 200063 |
Contrave NDC codes
Questions
Is there a generic for Contrave?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Contrave (naltrexone and bupropion). The Orange Book shows its last listed patent expires July 2, 2034.
What is the generic name for Contrave?
The active ingredient in Contrave is naltrexone and bupropion, per the FDA Orange Book.
When does the Contrave patent expire?
The last patent listed for Contrave in the Orange Book expires July 2, 2034. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.